SAVEMED

Microstructure secured and self-verifying medicines

Coordinatore	NANO-4-U GmbH    more  Organization address address: Mozartstrasse 7 city: Karlsruhe postcode: D-76133 contact info Titolo: Mr. Nome: Stefan Cognome: Klocke Email: send email Telefono: +49 176 60829741 Fax: +49 721 610102
Nazionalità Coordinatore	Germany [DE]
Totale costo	4˙278˙114 €
EC contributo	3˙144˙724 €
Programma	FP7-SECURITY Specific Programme "Cooperation": Security
Code Call	FP7-SEC-2010-1
Funding Scheme	CP
Anno di inizio	2011
Periodo (anno-mese-giorno)	2011-04-01   -   2014-03-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	NANO-4-U GmbH  Organization address address: Mozartstrasse 7 city: Karlsruhe postcode: D-76133 contact info Titolo: Mr. Nome: Stefan Cognome: Klocke Email: send email Telefono: +49 176 60829741 Fax: +49 721 610102	DE (Karlsruhe)	coordinator	939˙100.00
2	CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT  Organization address address: RUE JAQUET DROZ 1 city: NEUCHATEL postcode: 2007 contact info Titolo: Dr. Nome: Marc Cognome: Schnieper Email: send email Telefono: 41616906024 Fax: +41 61 6906000	CH (NEUCHATEL)	participant	971˙329.25
3	MAUER SPZOO  Organization address address: Krolow 37 city: Trzebiel postcode: 68 212 contact info Titolo: Mr. Nome: Holger Cognome: Tussing Email: send email Telefono: +49 721 9540 186 Fax: +49 721 57 40 12	PL (Trzebiel)	participant	270˙070.40
4	UNITED NATIONS INTERREGIONAL CRIME AND JUSTICE RESEARCH INSTITUTE  Organization address address: VIALE MAESTRI DEL LAVORO 10 city: TORINO postcode: 10127 contact info Titolo: Mr. Nome: Marco Cognome: Musumeci Email: send email Telefono: 41229175995 Fax: 41229170230	IT (TORINO)	participant	261˙855.00
5	KLOCKE HOLDING GMBH  Organization address address: MAX BECKER STRASSE 6 city: WEINGARTEN postcode: 76356 contact info Titolo: Ms. Nome: Petra Cognome: Jung Email: send email Telefono: +49 721 182 69 68 Fax: +49 7244 611170	DE (WEINGARTEN)	participant	241˙775.00
6	STERIPACK LTD  Organization address address: Kilbeggan Rd Clara city: CO OFFALY contact info Titolo: Dr. Nome: Gary Cognome: Leonard Email: send email Telefono: +353 5793 68158 Fax: +353 57 9331887	IE (CO OFFALY)	participant	234˙751.84
7	HELIOTIS AG  Organization address address: LANGENBOLD 5 city: ROOT postcode: 6037 contact info Titolo: Dr. Nome: Patrick Cognome: Lambelet Email: send email Telefono: +41 41 455 2220 Fax: +41 41 455 2221	CH (ROOT)	participant	225˙843.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Counterfeit medicines are a serious and fast expanding threat for the customer’s health and the pharmaceutical manufacturers business. The aim of this research collaboration is to add anti-counterfeiting and track & trace technology to the product level that goes beyond the state-of-the-art security approach on the packaging level. The project SAVEmed will bring a solution for the counterfeit and the illegal re-import problem in the medical product market, thereby ensuring product pedigree and defend illegal re-packing.

In SAVEmed project the direct marking of medical products with secure microstructures will be realised by modifying the tools used to manufacture the products as well as the ones used for their packages on the micron– and sub-micron level. The project aim is to transfer diffractive gratings, random microstructures, micro-barcodes and contrast generating micro-prisms in steel tools. Moreover, algorithm enabling cross checking of the secure microstructures on the product (even through coatings) and on the package will be developed to ensure the highest level of security possible. In SAVEmed this direct product marking approach will be realised for pharmaceutical tablets, injection moulded pharma caps and laminated sterile pouches. Nevertheless the approach is applicable to nearly all other types of medical products.

The strategies of criminal organisations will be analysed and the development will be adapted to counteract these strategies. Key advantage of the implementation of secure microstructures directly in or on the medical product itself is that no chemical or biological additives and that no costly changes of production lines are needed. Thus no additional approvals from regulatory agencies are requested.

This project will ensure a correct balance of market-pull and technological push by including major actors in anti-counterfeit technology research, 3 SMEs, 2 large industries and pre-assembled end-users External Advisory Board.'

Introduzione (Teaser)

A recent EU-funded project has developed microscopic physical markings for pharmaceutical and medical products to prevent counterfeiting.